If you can't read please download the document
Upload
sumit-prajapati
View
2.531
Download
22
Embed Size (px)
DESCRIPTION
Citation preview
2. WhatisNPC ? A very special type ofhead and neck cancer Different from other malignancies of the upperaerodigestive tract with regard to- Epidemiology, -Histology, -Clinical presentationsand -Treatment strategies. 3. N P C --- Canton Cancer
Why is it called Canton Cancer 4. Epidemiology
5. Evident geographic distribution difference
6. Evident geographic distribution difference
7.
Evident geographic distribution difference 8. ( ) 9. The High and Relatively High NPC Incidence Areas The Arctic Ocean Pacific Europe Asian Middle East Africa Oceania North America South America Latin America 10. Specific susceptible population
11. Specific susceptible population North America Eskimos 12. NPC incidence rates between Chinese immigrantsand other racial residents in Los Angeles and Singapore 0.2 0.2 Vietnamese 0.5 0.5 Indian 2.0 6.5 Malayan 7.3 18.5 Chinese Singapore 0.3 0.2 Japanese 0.3 3.8 Philippine 2.8 9.8 Chinese 0.2 1.0 Ethiopian 0.2 0.5 CaucasianLos Angeles female maleincidencerates(/10 5 /year) countryrace 13. NPCincidence Rate of Chinese in Sigapore(/10 5 ) 4.7 14.1 FuJian 1.3 6.2 ShangHai 4.8 12.6 KeJia 6.2 18.3 ChaoZhou 11.0 29.1 Cantonese Incidence Rate of NPC MaleFemale language 14. Death Rates in different dialectal populations in GuangDong Province(10 5 ) 1.96 5.32 KeJia 2.89 6.18 ChaoZhou 4.32-5.84 12.08-15.96 Cantonese Death Rate of NPC MaleFemale language 15. Family cluster phenomenon
16.
Family cluster phenomenon 17. FamousFamily maleNPC Breast Cancer femaleNPC Male Liver Cancer 34.2%cancers 26.3% NPC 18. 4 Stable Incidence Rate andMen to Women Ratio: 2 ~ 3.8 :1 Changes of Cancer Incidence Rateduring 30 Years 19. 5Differences Between High andLow Incidence Areas Two frequency age peaks: 16-19 and50-59Quickly increase after the age of 30, and reaches thepeak between 50-59 Ageof disease onset The Low Incidence Areas The High Incidence Areas 20. 5 Pathologydifferences between high andlow incidence areas Type I:Well-differentiated squamous carcinoma Type II:DifferentiatedNon-keratinising Carcinoma Type III:Undifferentiated Non-keratinising Carcinoma WHO histological classification of nasopharyngeal carcinoma Type I Type II Type III 21. 5Differences Between High andLow Incidence Areas Type II and III Type II and III The Low Incidence Areas The High Incidence Areas Well-differentiated squamous carcinoma accounts for 25%Type I Well-differentiated squamous carcinoma accounts for 1.67% Type I Pathology Type 22. Aetiology NPC Lung Cancer ExternalFactors Internal Factors Internal Factors ExternalFactors 23. Aetiology NPC EB-Virus HereditaryFactors Environmental Factors 24. Hereditary susceptibility
25. EBV---Epstein Barr Virus
26. EBV---Epstein Barr Virus
27. EnvironmentalFactors Nitrosamines salted fish laboratory mice cancer of nasal cavity cancer of nasopharynx Cantonese-style salted fish and other preserved foods 28. EnvironmentalFactors
29. (nickel sulfate) DNP( EvironmentalFactors (microelements) ( nickel) EB , (selenium) (calcium) 30. .Anatomy of Nasopharynx 31. Soft palate the torus sphenoid sinusclivus atlasaxis Pharyngealtonsil 32. .Anatomy of Nasopharynx lateral pharyngealRecess(fossa ofRosenmullar) the torus ( Eustachian tube ( ) nasal septumChoanae ( ) 33. lateral pharyngeal recess (Fossa of Rosenmullar) the torus Soft palate 34. * Ascending palatine Ascending pharyngeal -main External carotid A MaxillarySupplying vessels 35. Maxillary 36. jugulodigastric Rouvieres lymph nodes,Deep cervical lymph nodes, Supraclavicular lymph nodes Lymphatic Drainage Necknodes 37. Clinical presentations
38. Symptoms 1
39. jugulodigastric ( ) 40. Symptoms 2
41. Symptoms 3
42. Symptoms 4
43. Cranial Nerves
44. Cranial Nerve Damage
45. Exit of cranial nerves through bony base of skull Middle cranial fossa Posterior cranial fossa 46. Exit of cranial nerves through bony base of skull Optic foramen:II Cribriform plate:I Superior orbital fissure:III, IV, V 1 , VI 47. Exit of cranial nerves through bony base of skull Hypoglossal canal:XII Foramen rotundum: V 2 Foramen ovale:V 3 Internal auditory meatus:VII, VIII Jugular foramen:IX, X, XI 48. Optic foramen :II Superior orbital fissure :III, IV, V 1 VI Foramen rotundum :V 2 Foramen ovale :V 3 (Middle cranial fossa ) Internal auditory meatus :VII, VIII Jugular foramen :IX, X, XI Hypoglossal canal :XII (Posterior cranial fossa ) Exit of cranial nerves through bony base of skull 49. Cranial nerves III-VI are affected within theCavernous sinus III IV V 1 VIV 2 (Situated beside sella turcica) 50. Cavernous sinus (Situated beside sella turcica) 51. Cavernous sinus 52. ParapharyngealSpace Processus styloideus 53. Processus styloideus 54. Parapharyngeal Space 55. Parapharyngeal Space involvement 56. Nerves IX-XII are primarily affected in the Parapharyngeal Space below the skull base
57. Symptoms of commonly affected cranial nerves
58. Unilateralptosis oculomotor nerveparalysis 59.
Symptoms of commonly affected cranial nerves 60.
Symptoms of commonly affected cranial nerves 61. V1 V2 V3 62. (jaw tilt) ptosis) CN III V VI (+) 63.
Symptoms of commonly affected cranial nerves 64. 65. CN VI XII + Horner s + tongue lateralized toaffected side upon protrusion failure of abduction 66.
Symptoms of commonly affected cranial nerves 67.
Symptoms of commonly affected cranial nerves 68.
Symptoms of commonly affected cranial nerves 69. N 70. DiagnosisCTscan endoscopy laboratory 71. Procedure of diagnosis
72. Indirect mirror examination 73. With a forcep Rarely used Inconvenient 74. Direct transnasal endoscopic examination Widelyused 75. Anatomic Types NodularFungatingSubmucosalInverting UlceratingMixed 76. Imaging Study
77. Imaging Study 78. Imaging Study 79. Imaging Study 80. Imaging Study 81. MRI of NP---- better than CT 82. MRI of NP---- better than CT MRI is more sensitive thanCT in detecting tumors of the nasopharynx and its possible spread to nearby tissues or lymph nodes. 83. More examination To find Metastasis
84. PET(positron emission tomography)
85. PET/CT 86. PET/CT 87. PET/CT 88. Pathological study
89. Clinical Types of NPC Ascending Type -----Type of Cranial Nerves damage Descending Type -----Type of Lymphatic Metastasis MixedType Metastasis Type: 90. Ascending Type(Type of Cranial Nerves) Damages ofII III IV V cranial Nervesand/or skull baseBut No lymph node Metastasis 91. Descending Type (Type of Lymphatic Metastasis)
92. MixedType
93. Metastasis Type: 1.Bone 2.Liver 3.Lung 4.Other: abdominal nodes 94. Metastasis of NPC
95. PET/CT: dorsal vertebra lumbar vertebra 96. 97. Lung metastasis Liver metastasis 98. Differentiated diagnosis
99. Differential Diagnosis Adenoids 100. Differential Diagnosis Median Necrotic Granuloma tuberculosis 101. Fibroangioma 102. Clinical staging
103. NPC 92 Clinical Classification 104. T staging
105. N - MStaging
M0: no metastasis M1: metastasis 106. Treatment Option Radiotherapy:Radical Chemotherapy:Adjuvant Operation:Complementary 107. Treatmentprotocol -- stratifiedtherapy Radiotherapy Induction or Concomitant Adjuvant chemotherapy Radiotherapy Induction or Adjuvant chemotherapy N2-3 Radiotherapy Induction or Concomitant chemotherapy RadiotherapyN0-1 T3-4 T1-2 108. Brachytherapyis most often used to manage cancers that have recurred (come back) after treatment. It may also be used to treat the small original tumor. Intensity Modulated Radiation Therapy (IMRT) A new method of external radiation, known for delivering more effective doses of radiation while reducing the damage to healthy cells, thus causing fewer side effects. Stereotactic radiosurgerydelivers radiation therapy precisely to the tumor using a machine called agamma knife . This can be used to treat tumors that have invaded the base of the skull, or tumors that have recurred at the base of the brain or skull. 109. 80 110. 90 LN (Ia) 111. 112. Radiotherapy:Radical 113. 90 114. From Bucci, M. K. et al.CA Cancer J Clin 2005;55:117-134. 21 115. IMRT 116. IMRT 117. External beam radiation - complications
118. Chemotherapy: combined
119. Protocols of chemotherapy
120. 5-year survival of 351 cases aftercombined stratified therapy (92classification) 22% 50% 76% 90% Radiotherapy only (411 cases) 40.2% 62.3% 80% 95% Combined Therapy (351 cases) IVa III II I stage 121. Surgery-- for selected patients
122. 123. thanks for your attention !